Kidney and hypertension

Kidney International, Supplement

Volumn 61, Issue 80, 2002, Pages

  Adamczak, Marcin ^a   Zeier, Martin ^a   Dikow, Ralf ^a   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hypertension; Kidney; Renal disease; Renin angiotensin system; Sodium retention; Sympathetic nerve system

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; LISINOPRIL; LOSARTAN; METOPROLOL; MOXONIDINE; RAMIPRIL;

ADRENERGIC SYSTEM; BLOOD PRESSURE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; META ANALYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RETENTION; VASODILATATION; PATHOPHYSIOLOGY; RENOVASCULAR HYPERTENSION; REVIEW;

HUMANS; HYPERTENSION, RENAL;

EID: 0035999925     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.61.s80.28.x     Document Type: Conference Paper

References (57)

1. Renal function curve: A key to understanding the pathogenesis of hypertension
2. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive and normotensive rats
3. Role of the kidney in primary hypertension: A renal transplantation study in rats
4. Kidneys from normotensive donors lower blood pressure in young transplanted spontaneously hypertensive rats
5. Hypertension in man with a kidney transplant: Role of familial versus other factors
6. Hypertension in renal allograft recipients may be conveyed by cadaveric kidneys from donors with subarachnoidal haemorrhage
7. Remission of essential hypertension after renal transplantation
8. Tabular view of the morbid appearance in 100 cases connected with albominous urine with observation
9. Increased genetic risk of hypertension in glomerulonephritis?
10. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients
11. Nephropathy of type II diabetes: Evidence for hereditary factors?
12. Blood pressure in minimal change and other types of nephrotic syndrome
13. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis
14. The clinical course and pathology of hypertension with papilloedema (malignant hypertension)
15. The evolution of acute hypertensive arterial disease
16. Hypertensive vascular disease description and natural history
17. Blood pressure and end-stage renal disease in men
18. Early predictor of 15-year end-stage renal disease in hypertensive patients
19. Renal insufficiency in treated essential hypertension
20. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease
21. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
22. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy
23. Progression of renal insufficiency: Role of blood pressure
24. Blood pressure control, proteinuria and the progression of renal disease. The modification of diet in renal disease study
25. Ritz E for the collaborative transplant study: Association of chronic kidney graft failure with recipient blood pressure
26. Ambulatory blood pressure monitoring: Fancy gadgetry or clinical useful exercise?
27. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy
28. Progression of diabetic nephropathy - Is diurnal pressure rhythm as important as absolute blood pressure level
29. Non-dipper hypertensive patients and progressive renal insufficiency: A 3-year longitudinal study
30. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects
31. Reversed circadian blood pressure rhythm independently predicts endstage renal failure in non-insulin-dependent diabetes mellitus subjects
32. Standards of medical care for patients with diabetes mellitus
33. 1999 World Health Organization - International society of hypertension guidelines for the management of hypertension
34. Detection, evaluation, and treatment of high blood pressure (JNC VI)
35. A pivotal factor in the progression of renal diseases
36. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulo-interstinal fibrosis
37. The paradox of the low-renin state in diabetic nephropathy
38. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus
39. Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus
40. Effect of angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency
41. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric: Non-diabetic nephropathy
42. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
43. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
44. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
45. Pathophysiology of progressive nephropathies
46. Albumin and proximal tubular cells - Beyond endocytosis
47. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis
48. Dosing angiotensin II blockers-beyond blood pressure
49. Modulation of the renin-angiotensin system in proteinuric renal disease: Are there added benefits?
50. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function
51. Renal afferent denervation prevents hypertension in rats with chronic renal failure
52. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat
53. Sympathetic overactivity in patients with chronic renal failure
54. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats
55. Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and β blockers
56. Lowering of microalbuminuria in diabetic patients by a symphatoplegic agent: A novel approach to prevent progression of diabetic nephropathy?